VIVO Trademark

Trademark Overview


On Monday, June 2, 2025, a trademark application was filed for VIVO with the United States Patent and Trademark Office. The USPTO has given the VIVO trademark a serial number of 99213571. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, December 17, 2025. This trademark is owned by OmniScience, Inc.. The VIVO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services, namely, hosting software for use by others for clinical and operational data processing in the field of life sciences and clinical trials; providing temporary use of non-downloadable software for clinical data integration, statistical analysis, monitoring, and management in clinical research; artificial intelligence as a service (AIaaS) featuring software for clinical and operational data processing, monitoring, forecasting, clustering, agentic search and workflow automation, and decision support in clinical trials; scientific and technological services, namely, analysis for clinical trial operations, featuring clinical data harmonization, risk analysis, and performance benchmarking
vivo

General Information


Serial Number99213571
Word MarkVIVO
Filing DateMonday, June 2, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, December 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSoftware as a service (SAAS) services, namely, hosting software for use by others for clinical and operational data processing in the field of life sciences and clinical trials; providing temporary use of non-downloadable software for clinical data integration, statistical analysis, monitoring, and management in clinical research; artificial intelligence as a service (AIaaS) featuring software for clinical and operational data processing, monitoring, forecasting, clustering, agentic search and workflow automation, and decision support in clinical trials; scientific and technological services, namely, analysis for clinical trial operations, featuring clinical data harmonization, risk analysis, and performance benchmarking

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeP - NOT AVAILABLE
Class Status DateMonday, June 2, 2025
Primary Code042
First Use Anywhere DateMonday, June 1, 2020
First Use In Commerce DateMonday, November 8, 2021

Trademark Owner History


Party NameOmniScience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77021

Trademark Events


Event DateEvent Description
Monday, June 2, 2025NEW APPLICATION ENTERED
Monday, June 2, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, October 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 21, 2025ASSIGNED TO EXAMINER
Thursday, October 23, 2025NON-FINAL ACTION WRITTEN
Thursday, October 23, 2025NON-FINAL ACTION E-MAILED
Thursday, October 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 25, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 26, 2025FINAL REFUSAL WRITTEN
Wednesday, November 26, 2025FINAL REFUSAL E-MAILED
Wednesday, November 26, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 26, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 17, 2025NON-FINAL ACTION WRITTEN
Wednesday, December 17, 2025NON-FINAL ACTION E-MAILED
Wednesday, December 17, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED